WO2002074952A3 - Gegen abbau stabilisierte nukleinsäure - Google Patents

Gegen abbau stabilisierte nukleinsäure Download PDF

Info

Publication number
WO2002074952A3
WO2002074952A3 PCT/DE2002/001048 DE0201048W WO02074952A3 WO 2002074952 A3 WO2002074952 A3 WO 2002074952A3 DE 0201048 W DE0201048 W DE 0201048W WO 02074952 A3 WO02074952 A3 WO 02074952A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
against decomposition
molecule
stabilised against
constituents
Prior art date
Application number
PCT/DE2002/001048
Other languages
English (en)
French (fr)
Other versions
WO2002074952A2 (de
Inventor
Helmut Merk
Wolfgang Stiege
Original Assignee
Rina Netzwerk Rna Technologien
Helmut Merk
Wolfgang Stiege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10113265.4A external-priority patent/DE10113265B4/de
Priority claimed from DE10151071A external-priority patent/DE10151071A1/de
Application filed by Rina Netzwerk Rna Technologien, Helmut Merk, Wolfgang Stiege filed Critical Rina Netzwerk Rna Technologien
Priority to JP2002574343A priority Critical patent/JP4386641B2/ja
Priority to DE50214042T priority patent/DE50214042D1/de
Priority to AT02732338T priority patent/ATE450616T1/de
Priority to AU2002304871A priority patent/AU2002304871A1/en
Priority to EP02732338A priority patent/EP1370664B1/de
Priority to US10/471,936 priority patent/US20050118580A1/en
Publication of WO2002074952A2 publication Critical patent/WO2002074952A2/de
Publication of WO2002074952A3 publication Critical patent/WO2002074952A3/de
Priority to US13/223,427 priority patent/US20120142048A1/en
Priority to US13/922,393 priority patent/US20140120576A1/en
Priority to US14/551,696 priority patent/US20150079629A1/en
Priority to US14/804,818 priority patent/US20160177320A1/en
Priority to US15/292,633 priority patent/US20170029828A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Die Erfindung betrifft eine gegen Abbau durch Exonukleasen stabilisierte Nukleinsäure mit folgenden Komponenten: a) einer für ein definiertes Protein codierenden Codesequenz, b) optional, einer die Expression der Codesequenz kontrollierenden Promotorsequenz und c) zumindest einem an einem Ende der linearen Sequenz enthaltend die Komponenten a und b angefügten Molekül A, welches mit einem nicht-immobilisierten volumigen Molekül B verbunden ist.
PCT/DE2002/001048 2001-03-16 2002-03-18 Gegen abbau stabilisierte nukleinsäure WO2002074952A2 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2002574343A JP4386641B2 (ja) 2001-03-16 2002-03-18 分解に対して安定化した核酸
DE50214042T DE50214042D1 (de) 2001-03-16 2002-03-18 Gegen abbau stabilisierte nukleinsäure
AT02732338T ATE450616T1 (de) 2001-03-16 2002-03-18 Gegen abbau stabilisierte nukleinsäure
AU2002304871A AU2002304871A1 (en) 2001-03-16 2002-03-18 Nucleic acid which is stabilised against decomposition
EP02732338A EP1370664B1 (de) 2001-03-16 2002-03-18 Gegen abbau stabilisierte nukleinsäure
US10/471,936 US20050118580A1 (en) 2001-03-16 2002-03-18 Nucleic acid which is stabilized against decomposition
US13/223,427 US20120142048A1 (en) 2001-03-16 2011-09-01 Nucleic acid which is stabilized against decomposition
US13/922,393 US20140120576A1 (en) 2001-03-16 2013-06-20 Nucleic acid which is stabilized against decomposition
US14/551,696 US20150079629A1 (en) 2001-03-16 2014-11-24 Nucleic acid which is stabilized against decomposition
US14/804,818 US20160177320A1 (en) 2001-03-16 2015-07-21 Nucleic acid which is stabilized against decomposition
US15/292,633 US20170029828A1 (en) 2001-03-16 2016-10-13 Nucleic acid which is stabilized against decomposition

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE10145014 2001-03-16
DE10145014.1 2001-03-16
DE10113265.4A DE10113265B4 (de) 2001-03-16 2001-03-16 Verwendung einer stabilisierten Nukleinsäure zur Herstellung eines Proteins
DE10113265.4 2001-03-16
DE10151071.3 2001-10-05
DE10151071A DE10151071A1 (de) 2001-03-16 2001-10-05 Gegen Abbau stabilisierte Nukleinsäure

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/471,936 A-371-Of-International US20050118580A1 (en) 2001-03-16 2002-03-18 Nucleic acid which is stabilized against decomposition
US13/223,427 Continuation US20120142048A1 (en) 2001-03-16 2011-09-01 Nucleic acid which is stabilized against decomposition

Publications (2)

Publication Number Publication Date
WO2002074952A2 WO2002074952A2 (de) 2002-09-26
WO2002074952A3 true WO2002074952A3 (de) 2003-05-30

Family

ID=27214349

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/001048 WO2002074952A2 (de) 2001-03-16 2002-03-18 Gegen abbau stabilisierte nukleinsäure

Country Status (4)

Country Link
US (6) US20050118580A1 (de)
EP (1) EP1370664B1 (de)
JP (1) JP4386641B2 (de)
WO (1) WO2002074952A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006015321A1 (de) * 2006-03-30 2007-10-04 Rina-Netzwerk Rna Technologien Gmbh Verfahren zur Genexpression
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
ATE523603T1 (de) * 2008-11-21 2011-09-15 Chimera Biotec Gmbh Konjugatkomplexe zum analytnachweis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020676A1 (en) * 1994-01-31 1995-08-03 Inceltec Limited In situ nucleic acid amplification
EP0743367A2 (de) * 1995-05-19 1996-11-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Verfahren zur Genexpressionsanalyse
EP1251179A2 (de) * 2001-04-18 2002-10-23 Roche Diagnostics GmbH Methode für Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in einem zellfreien in vitro Transkriptions-/Translationssystem mit exonukleaseenthaltenden Lysaten oder in einem zellulären exonukleaseenthaltenden System

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6447952A (en) * 1987-05-06 1989-02-22 Saibaafuruua Inc Immunoassay, reagent used therefor and making thereof
CA1322735C (en) * 1987-11-07 1993-10-05 Shinichiro Haze Microorganism having low acetate forming capability, and process for production of useful substrate using same
US5134071A (en) * 1989-02-06 1992-07-28 State University Of New York Polymerization and copolymerization of proteins
US6120991A (en) * 1990-10-30 2000-09-19 Fred Hutchinson Cancer Research Center Epiligrin, an epithelial ligand for integrins
US5652099A (en) * 1992-02-12 1997-07-29 Conrad; Michael J. Probes comprising fluorescent nucleosides and uses thereof
EP1496120B1 (de) * 1997-07-07 2007-03-28 Medical Research Council Ein in vitro Sortierverfahren

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020676A1 (en) * 1994-01-31 1995-08-03 Inceltec Limited In situ nucleic acid amplification
EP0743367A2 (de) * 1995-05-19 1996-11-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Verfahren zur Genexpressionsanalyse
EP1251179A2 (de) * 2001-04-18 2002-10-23 Roche Diagnostics GmbH Methode für Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in einem zellfreien in vitro Transkriptions-/Translationssystem mit exonukleaseenthaltenden Lysaten oder in einem zellulären exonukleaseenthaltenden System

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IHLE O ET AL: "Efficient purification of DNA fragments using a protein binding membrane.", NUCLEIC ACIDS RESEARCH. ENGLAND 15 AUG 2000, vol. 28, no. 16, 15 August 2000 (2000-08-15), pages E76, XP002230673, ISSN: 1362-4962 *

Also Published As

Publication number Publication date
JP4386641B2 (ja) 2009-12-16
EP1370664B1 (de) 2009-12-02
US20120142048A1 (en) 2012-06-07
US20140120576A1 (en) 2014-05-01
US20160177320A1 (en) 2016-06-23
US20170029828A1 (en) 2017-02-02
US20150079629A1 (en) 2015-03-19
EP1370664A2 (de) 2003-12-17
JP2004524035A (ja) 2004-08-12
WO2002074952A2 (de) 2002-09-26
US20050118580A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
AU2003272141A1 (en) Two-dimensional code having superior decoding property which is possible to control the level of error correcting codes, and method for encoding and decoding the same
HK1108704A1 (en) Method for purifying fsh fsh
WO2002014485A3 (en) Kallikrein gene
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
BR0213411A (pt) Proteìna de metabolização de herbicida, seu gene e uso
WO2004024625A3 (en) Composition and method for producing carbon dioxide
HUP0303517A2 (hu) Hímfertilitást közvetítő nukleotidszekvenciák és alkalmazásuk
EP2369010A3 (de) Nitrilhydratasen aus Metagenom
WO2002074952A3 (de) Gegen abbau stabilisierte nukleinsäure
WO2005091777A3 (en) Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides
WO2005067410A3 (en) Synthetic nucleic acids from aquatic species
WO2001062781A3 (de) Homogentisatphytyltransferase
WO1999001548A3 (en) Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
WO2002059322A3 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
WO2003014297A3 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
WO1996016175A3 (en) Lgmd gene coding for a calcium dependent protease
WO2004094025A3 (en) Method of removing hexafluoropropylene dimers
BR0212585A (pt) Processos para a preparação de hidroperóxidos orgânicos, de compostos de oxirana e de uma alquenilarila
WO2007071578A3 (de) Verfahren zur herstellung von 5 -norbornen-2-carbonsäure aus 5-norbornen-2-carbonitril unter verwendung einer arylacetonitrilase
WO2002059345A3 (en) Nucleic acid encoding ion transporter component protein
WO2004028562A3 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
WO2002061074A1 (fr) Nouvelle proteine et adn la comprenant
GB0120437D0 (en) Diabetic model
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
AU2002253332A1 (en) Codon-optimised nucleic acid coding for apoaequorin and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002574343

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002732338

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002732338

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10471936

Country of ref document: US